Epsilon M&A Deal Report - TAD Pharma
Transaction Multiples for the Valuation of Private Companies
Krka Dd / TAD Pharma
No EMAT :
18591
Announced Date :
08/11/2007
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Krka Dd
Target :
TAD Pharma
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
TAD Pharma operates as a generic supplier in the pharmaceutical market in Germany. It focuses on drugs for cardiovascular, central nervous system and urogenital diseases. The company offers its...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/11/2007 | Private Group Led by Healthpoint II Sarl | Ideal Medical Products | France | ** | 18572 |
| 03/08/2007 | Immunodiagnostic Systems Holdings | Biocode Hycel | Belgium | ** | 18564 |
Source: Epsilon Research / EMAT
